IN8bio Inc.
INAB | NASDAQ
$1.12
+$0.06 (+5.66%)
Sep 22, 2026, 11:57 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -19.44M | -30.44M | -30.01M | -28.52M | -14.65M | -8.56M |
Depreciation & Amortization | 1.77M | 2.66M | 2.5M | 1.1M | 788K | 88K |
Stock-Based Compensation | 3.19M | 5M | 4.37M | 3.47M | 2.2M | 357K |
Other Working Capital | 1.12M | -877K | 777K | -1.68M | -1.52M | 771K |
Other Non-Cash Items | 730K | 45K | n/a | 4.16M | 541K | 368K |
Deferred Income Tax | n/a | n/a | n/a | -4.16M | -541K | n/a |
Change in Working Capital | 1.04M | -1.41M | -204K | -170K | -1.84M | 611K |
Operating Cash Flow | -12.71M | -24.15M | -23.34M | -24.12M | -13.51M | -7.13M |
Capital Expenditures | n/a | -104K | -600K | -3.71M | -309K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -83K | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -187K | -600K | -3.71M | -309K | n/a |
Debt Repayment | -693K | -794K | -798K | -615K | -709K | 174K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 5.04M | n/a | 61K | -2.66M | -1.33M |
Financial Cash Flow | 28.64M | 14.18M | 27.04M | 8.99M | 32.96M | 24.52M |
Net Cash Flow | 15.93M | -10.15M | 3.1M | -18.84M | 19.14M | 17.38M |
Free Cash Flow | -12.71M | -24.25M | -23.94M | -27.83M | -13.82M | -7.13M |
Adj. Free Cash Flow | -15.9M | -29.25M | -28.31M | -31.29M | -16.01M | -7.49M |
Maintenance CapEx | n/a | -104K | -600K | -1.1M | -309K | n/a |
Growth CapEx | n/a | n/a | n/a | -2.6M | n/a | n/a |
Owner Earnings | -12.71M | -24.25M | -23.94M | -25.22M | -13.82M | -7.13M |
Add to Watchlist
Select watchlists to add or remove INAB